Contact information
daniel.prietoalhambra@ndorms.ox.ac.uk
Mahkameh Mafi
mahkameh.mafi@ndorms.ox.ac.uk
Research groups
Websites
-
Athena SWAN
Self assessment-team
- European Health Data & Evidence Network (EHDEN)
- EU ADR Alliance
- International Society of Pharmacoepidemiology (ISPE)
-
National Institute for Health Research (NIHR)
Faculty (NIHR Clinician Scientist)
- Observational Health Data Sciences and Informatics (OHDSI)
-
SIDIAP Database
International Coordinator
- Erasmus MC University - Medical Informatics
Dani Prieto-Alhambra
MD MSc(Oxf) PhD
Professor of Pharmaco- and Device Epidemiology
- Section Head, Health Data Sciences, Botnar Research Centre
- NIHR Senior Research Fellow
- Fellow of the International Society of Pharmaco-Epidemiology, FISPE
Real World Evidence, Pharmaco-epidemiology, Device Epidemiology
I am an epidemiologist and academic clinician scientist using routinely collected (real world) health data to generate reliable evidence for improved patient care.
Through an NIHR Senior Research Fellowship, I am investigating the use, safety, effectiveness and cost of drugs and devices as used in usual practice conditions and amongst older people with complex health needs.
I lead Pharmaco- and Device Epidemiology research at NDORMS, and have experience designing, analysing and interpreting electronic medical records from around the world. I’ve worked on multiple real world data assets nationally and internationally, and have specialized in network studies using the OMOP Common Data Model.
More recently, I have joined the European Health Data & Evidence Network EHDEN (www.ehden.eu) and the Observational Health Data Sciences and Informatics OHDSI (www.ohdsi.org) in an effort to accelerate and improve the quality of real world evidence internationally.
From February 2022, I am Deputy Director for the European Medicines Agency's Data Analysis and Real World Interrogation Network (DARWIN EU) Coordination Centre, and lead the Development pillar for the generation and/or validation of analytical tools to generate real world evidence for regulatory use.